Exceeding nearly 4500 lncRNA-cancer entries over the previous version. The current release recruits 9,254 lncRNA-cancer associations with 2,659 lncRNAs and 216 cancer subtypes.
Newly adding about 1,049 experimentally supported circRNA-cancer associations with 743 circRNAs and 70 human cancer subtypes.
Newly adding experimentally supported regulatory mechanisms section of cancer-related lncRNAs and circRNAs including microRNA, Transcription factor, variant, methylation and enhancer.
Appending the experimentally supported biological function section of cancer-related lncRNAs and circRNAs including cell growth, apoptosis, autophagy, Epithelial mesenchymal transformation, immune and coding ability.
Adding experimentally supported clinical application section of cancer-related lncRNAs and circRNAs including metastasis, recurrence, circulating, drug-resistance and prognosis.
Newly providing an interactive analysis platform for users to compute and visualization interested lncRNAs in cancers.
Newly adding a single cell analysis platform for exploring lncRNAs in cancers.
Please cite:Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data, (Nucleic Acids Research, 2020)
2020, CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.